Document and Entity Information
Document and Entity Information | Oct. 06, 2023 |
Document Type | 8-K |
Document Period End Date | Oct. 06, 2023 |
Entity Registrant Name | Ambrx Biopharma Inc. |
Entity Incorporation, State or Country Code | E9 |
Securities Act File Number | 001-40505 |
Entity Tax Identification Number | 00-0000000 |
Entity Address, Address Line One | 10975 North Torrey Pines Road |
Entity Address, City or Town | La Jolla |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92037 |
City Area Code | 858 |
Local Phone Number | 875-2400 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Amendment Flag | false |
Entity Central Index Key | 0001836056 |
Ordinary Shares, Par Value US $0.0001 Per Share [Member] | |
Title of 12(b) Security | Ordinary shares, par value US $0.0001 per share |
Security Exchange Name | NASDAQ |
No Trading Symbol Flag | true |
American Depositary Shares, Each Representing Seven Ordinary Shares, Par Value US $0.0001 Per Share [Member] | |
Title of 12(b) Security | American Depositary Shares, each representing seven ordinary shares, par value US $0.0001 per share |
Security Exchange Name | NASDAQ |
Trading Symbol | AMAM |